Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Fasciano KM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Morris SE; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts, USA., Ryan AK; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Malinowski P; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pozo-Kaderman C; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2024 Apr; Vol. 13 (2), pp. 281-287. Date of Electronic Publication: 2023 Oct 23.
Autor:
Umaretiya PJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Vega B; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rodrigues G; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Josephs I; Brown Medical School, Providence, Rhode Island, USA., Brock KE; Divisions of Pediatric Oncology and Palliative Care, Emory University, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Buchanan S; BeiGene, Cambridge, Massachusetts, USA., Casperson M; Cactus Cancer Society, Oakland, California, USA., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kolevska T; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, California, USA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, California, USA., Shalman DM; Department of Palliative Care, Kaiser Permanente Southern California, Pasadena, California, USA., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, Maryland, USA., Bona K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Jan; Vol. 70 (1), pp. e30035. Date of Electronic Publication: 2022 Oct 29.
Autor:
Odejide OO; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA., Vega B; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Rodrigues G; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Josephs I; Brown Medical School, Providence, RI., Brock KE; Division of Pediatric Oncology, Emory University, Atlanta, GA.; Division of Palliative Care, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA., Buchanan S; Agios Pharmaceuticals, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Casperson M; Cactus Cancer Society, Oakland, CA., Cooper RM; Pediatric Oncology, Kaiser Permanente Southern California, Pasadena, CA., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Kolevska T; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA., Shalman DM; Palliative Care, Kaiser Permanente Southern California, Pasadena, CA., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, MD., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2022 Oct; Vol. 18 (10), pp. e1621-e1629. Date of Electronic Publication: 2022 Aug 18.
Autor:
Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Kushi L; Division of Research, Kaiser Permanente Northern California, Oakland., Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena., Vega B; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Rodrigues G; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Josephs I; Brown Medical School, Providence, Rhode Island., Brock KE; Divisions of Pediatric Oncology and Palliative Care, Emory University and Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia., Buchanan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Now with Agios Pharmaceuticals, Cambridge, Massachusetts., Casperson M; Lacuna Loft, Oakland, California., Cooper RM; Department of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Kolevska T; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland., Lakin JR; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Lefebvre A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz CM; Division of Medical Oncology, Kaiser Permanente Northern California, Oakland., Shalman DM; Department of Palliative Care, Kaiser Permanente Southern California, Pasadena., Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wiener L; Psychosocial Support and Research Program, National Cancer Institute, Bethesda, Maryland., Altschuler A; Division of Research, Kaiser Permanente Northern California, Oakland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2021 Aug 02; Vol. 4 (8), pp. e2121888. Date of Electronic Publication: 2021 Aug 02.
Autor:
Morris SE; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts, USA., Souza PM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2021 Jun; Vol. 10 (3), pp. 260-265. Date of Electronic Publication: 2020 Nov 06.
Autor:
Greenzang KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Fasciano KM; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA., Block SD; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2020 Jul 15; Vol. 126 (14), pp. 3281-3288. Date of Electronic Publication: 2020 May 04.
Autor:
Gittzus JA; Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts., Fasciano KM; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts., Block SD; Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Psycho-oncology [Psychooncology] 2020 Mar; Vol. 29 (3), pp. 572-578. Date of Electronic Publication: 2019 Dec 11.
Autor:
Mack JW; Division of Population Sciences, Department of Pediatric Oncology, McGraw/Patterson Center for Outcomes and Policy Research and jennifer_mack@dfci.harvard.edu.; Division of Hematology and Oncology, Boston Children's Hospital, Boston, Massachusetts; and., Fasciano KM; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.; Departments of Psychiatry and., Block SD; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.; Departments of Psychiatry and.; Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
Pediatrics [Pediatrics] 2019 May; Vol. 143 (5).
Autor:
Poort H; 1 Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute , Boston, Massachusetts., Souza PM; 2 Oncology Palliative Care Clinic, Providence Cancer Institute , Portland, Oregon., Malinowski PK; 1 Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute , Boston, Massachusetts., MacDougall KM; 1 Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute , Boston, Massachusetts., Barysauskas CM; 3 Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute , Boston, Massachusetts., Lau Greenberg T; 4 Department of Quality and Patient Safety, Dana-Farber Cancer Institute , Boston, Massachusetts., Tulsky JA; 1 Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute , Boston, Massachusetts.; 5 Division of Palliative Medicine, Brigham and Women's Hospital , Boston, Massachusetts., Fasciano KM; 1 Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute , Boston, Massachusetts.; 6 Department of Psychiatry, Brigham and Women's Hospital , Boston, Massachusetts.
Publikováno v:
Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2018 Oct; Vol. 7 (5), pp. 565-571. Date of Electronic Publication: 2018 May 21.